Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...

A medical device company has secured investment from the owner of the developer of Ozempic and a private equity firm, to ...

Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to ...

Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.

Additional investment and resources will accelerate Biocomposites' international expansion and innovation in products for use in infection management HELLERUP, Denmark, LONDON and KEELE ...

The company’s founders, management team, and existing investors, which include Springcoast, GV, Polaris, and Kleiner Perkins, will retain significant ownership in Egnyte.

Van ECK Associates Corp boosted its stake in TransAlta Co. (NYSE:TAC – Free Report) (TSE:TA) by 7.5% in the fourth quarter, ...

Private equity firms Carlyle Group Inc. and Thoma Bravo are among the suitors shortlisted in the bidding for French software ...

Bellevue, Wash.-based health software company Edifecs announced has agreed to be acquired by Cotiviti, a Utah-based healthcare giant backed by private equity firms. Terms of the deal were not ...

There’s talk in the market that TA Associates has its eye on a big deal and is active in the local market. There’s a number of opportunities which could catch its eye. One suggestion is the ...